首页 > 市场调查报告书 > 製药

北美智慧生命科学製造市场预测至 2028 年 - 区域分析 - 按组件（解决方案和服务）、技术、最终用途行业（製药、生物製药和医疗器材）

市场调查报告书

商品编码

1393988

北美智慧生命科学製造市场预测至 2028 年 - 区域分析 - 按组件（解决方案和服务）、技术、最终用途行业（製药、生物製药和医疗器材）

North America Smart Life Sciences Manufacturing Market Forecast to 2028 - Regional Analysis - by Component (Solutions and Services), Technology, End use industry (Pharma, Bio-Pharma, and Medical Device)

出版日期: 2023年10月11日 | 出版商:

The Insight Partners | 英文 176 Pages | 订单完成后即时交付

价格

简介目录图表

北美智慧生命科学製造市场预计将从2023年的61.0189亿美元成长到2033年的225.7568亿美元。预计2023年至2033年CAGR为14.0%。

製药 4.0 的采用不断增加推动北美智慧生命科学製造市场

科技在医疗保健领域一直发挥着重要作用，其中与肿瘤学、神经学和免疫学等其他领域相比，生物技术产业是资料分析领域最新技术进步中受益最大的领域。新兴资料科学技术也有助于生物技术产业的发展。生物体分析、新药研究等是生物技术实验室发挥的主要作用。

现代资料分析工具使生物技术研究人员能够创建预测分析模型，并最终使他们了解实现其预期目的和目标的最有效方法。大资料、人工智慧、虚拟实境、资料视觉化和资料安全是生物技术实验室常用的技术。 Tableau 帮助 Novozymes 将报表时间缩短了 90% 以上。它还协助公司部门内的策略决策，如销售、原材料采购、规划和财务。此外，Tableau 还允许 Novozymes 的销售人员与客户分享关键见解，从而建立关係并提高收入绩效。

阿斯特捷利康 (AstraZeneca, plc) 是一家英国-瑞典跨国製药和生物技术公司，利用资料和技术来最大限度地缩短发现和交付潜在新药的时间。该公司的研发部门嵌入了资料科学和人工智慧功能，使科学家能够突破科学的界限，提供改变生活的药物。他们将人工智慧应用于从目标识别到临床试验的整个发现和开发过程，以发现指导药物发现和开发过程的新见解。 Atomwise 是一家总部位于加州的公司，也利用人工智慧来推进小分子药物的发现。该公司与康乃狄克大学合作，与康乃狄克大学研究人员合作研究针对 COVID-19 的药物标靶。

北美智慧生命科学製造市场概况

北美是全球已开发地区之一。由于人工智慧（AI）、物联网（IoT）、机器学习（ML）、云端运算和巨量资料先进技术的广泛采用，美国在生命科学市场的智慧生命科学製造中占据最大份额分析。北美地区对此类技术的采用率很高，并且有微软公司和 IBM 公司等各种科技巨头。这些科技公司为生命科学和医疗保健产业提供技术。此外，该地区还拥有生命科学行业的各种主要製造商，例如辉瑞（Pfizer）和通用电气医疗保健（GE HealthCare）。这些製造商利用智慧製造技术来生产和製造药品和医疗器材。此外，在COVID-19大流行期间，智慧製造技术的使用增加，使生产单元自动化，员工之间的接触有限，以确保安全。例如，2019 年，Phillips 选择 Atos 来设计和实施 IT 转型计划，以建立混合云模型。该交易历时四年半，预计将帮助飞利浦满足客户的需求，并提供灵活性来满足其不断变化的业务和技术要求。飞利浦的 IT 转型预计将在未来几年推动医疗保健创新。

北美智慧生命科学製造市场收入及 2033 年预测（百万美元）

北美智慧生命科学製造市场细分

北美智慧生命科学製造市场分为技术、组件、最终用途产业和国家。

根据组件，北美智慧生命科学製造市场分为解决方案和服务。 2023年，解决方案领域在北美智慧生命科学製造市场中占据更大份额。

根据技术领域分为 AR/VR 系统、物联网 (IOT)、人工智慧 (AI)、网路安全、大数据等。 2023年，物联网领域在北美智慧生命科学製造市场中占据最大份额。

根据最终用途产业，北美智慧生命科学製造市场分为製药、生物製药和医疗器材。 2023年，医疗器材领域在北美智慧生命科学製造市场中占据最大份额。

依国家/地区划分，北美智慧生命科学製造市场分为美国、加拿大和墨西哥。 2023年，美国主导北美智慧生命科学製造市场。

ABB Ltd、博世力士乐股份公司、艾默生电气公司、Fortinet Inc、通用电气公司、霍尼韦尔国际公司、国际商业机器公司、罗克韦尔自动化公司、西门子股份公司和Sophos Ltd 是北美智慧生活领域的一些领先公司科学製造市场。

市场驱动因素
- 製药 4.0 的采用率不断上升
- 生物技术实验室越来越多地使用技术
市场限制
- 存在技能差距和需要高额初始投资
市场机会
- 人工智慧在癌症研究的应用
- 智慧工厂采用虚拟实境
未来的趋势
- 连接到资料孤岛
- 区块链的使用
- 边缘运算
- 预测性维护
- 基于愿景的品质管理
- 智慧工厂趋势
- 工业5.0的出现
驱动因素和限制因素的影响分析

第 6 章：北美智慧生命科学製造市场 - 北美分析

概述

第 7 章：北美智慧生命科学製造市场分析 - 按组成部分

概述
北美智慧生命科学製造市场，按组成部分（2022 年和 2033 年）
解决方案
服务

第 8 章：北美智慧生命科学製造市场分析 - 按技术

概述
北美智慧生命科学製造市场，按技术划分（2022 年和 2033 年）
AR/VR系统
物联网 (IOT)
人工智慧
网路安全
大数据
其他的

第 9 章：北美智慧生命科学製造市场分析 - 按最终用途产业

概述
北美智慧生命科学製造市场，依最终用途产业划分（2022 年和 2033 年）
製药公司
生物製药
医疗装置

第 10 章：北美智慧生命科学製造市场分析 - 按国家/地区

北美：北美智慧生命科学製造市场概况

第 11 章：产业格局

概述
市场计划、扩张和策略发展
新产品/功能开发
併购
协议、合作和合资企业

第 12 章：公司简介

ABB Ltd
Bosch Rexroth AG
Emerson Electric Co
Fortinet Inc
General Electric Co
Honeywell International Inc
International Business Machines Corp
Rockwell Automation Inc
Siemens AG
Sophos Ltd.

第 13 章：附录

关于 Insight Partners
词索引

简介目录图表

Product Code: BMIRE00028927

The North America Smart Life Sciences Manufacturing Market is expected to grow from US$ 6,101.89 million in 2023 to US$ 22,575.68 million by 2033. It is estimated to grow at a CAGR of 14.0% from 2023 to 2033.

Rising Adoption of Pharma 4.0 Fuel North America Smart Life Sciences Manufacturing Market

Technology has been playing a major role in the healthcare sector, wherein the biotechnology industry is the most benefited segment by recent technological advancements in data analytics, compared to other domains such as oncology, neurology, and immunology. Emerging data sciences technologies also assist in the growth of the bIoTechnology industry. The analysis of living organisms, research for novel drugs, etc., are the major roles played by bIoTechnology laboratories.

Modern data analytics tools have allowed bIoTechnology researchers to create predictive analytics models and eventually allow them to understand the most effective ways of achieving their desired goals and objectives. Big data, AI, virtual reality, data visualization, and data security are among the common technologies used in biotech laboratories. Tableau helped Novozymes cut the reporting times by more than 90%. It also assists in strategic decision-making within the company's departments such as sales, raw material purchase, +planning, and finance. In addition, Tableau allows Novozymes' sales force in sharing key insights with customers, thereby building relationships and enhancing revenue performance.

AstraZeneca, plc, a British-Swedish multinational pharmaceutical and bIoTechnology company, uses data and technology to minimize the time to discovery and delivery of potential new medicines. The company has data science and AI capabilities embedded in its R&D departments, which allows scientists to push the boundaries of science to deliver life-changing medicines. They apply AI throughout the discovery and development process, from target identification to clinical trials, to uncover new insights guiding the drug discovery and development process. Atomwise, a California-based company, also uses AI to advance small molecule drug discovery. The company partnered with Uconn to collaborate with UConn researchers on the investigation of drug targets against COVID-19.

North America Smart Life Sciences Manufacturing Market Overview

North America is one of the developed regions across the world. The US holds the largest share of the smart life sciences manufacturing in life science market owing to high adoption of advance technologies such as artificial intelligence (AI), Internet of Things (IoT), machine learning (ML), cloud computing, and big data analytics. The North American region has high adoption of such technologies along with the presence of various tech giants such as Microsoft Corporation and IBM Corporation. These tech companies provide technologies to the life sciences & healthcare industry. Additionally, the region houses various major manufacturers from the life science industry such as Pfizer and GE HealthCare. These manufacturers use smart manufacturing technologies to produce and manufacture pharmaceutical and medical devices. Moreover, during COVID-19 pandemic, the use of smart manufacturing technologies increased to automate the production units with limited contact among employees to ensure safety. For instance, in 2019 Phillips selected Atos to design and implement an IT transformation program to build a hybrid cloud model. The deal was done for four and a half years and is expected to help Philips in meeting the needs of their customers and provides flexibility to meet its evolving business and technology requirements. The IT transformation of Phillips is expected to drive healthcare innovation in the coming years.

North America Smart Life Sciences Manufacturing Market Revenue and Forecast to 2033 (US$ Million)

North America Smart Life Sciences Manufacturing Market Segmentation

The North America smart life sciences manufacturing market is segmented into technology, component, end use industry, and country.

Based on component, the North America smart life sciences manufacturing market is segmented into solutions and services. The solution segment held a larger share of the North America smart life sciences manufacturing market in 2023.

Based on technology segment is categorized into AR/VR Systems, Internet of things (IOT), Artificial Intelligence (AI), Cybersecurity, Big Data, and others. The Internet of things segment held the largest share of the North America smart life sciences manufacturing market in 2023.

Based on end use industry, the North America smart life sciences manufacturing market is segmented into pharma, bio-pharma, and medical devices. The medical device segment held the largest share of the North America smart life sciences manufacturing market in 2023.

Based on country, the North America smart life sciences manufacturing market is segmented into the US, Canada, and Mexico. The US dominated the North America smart life sciences manufacturing market in 2023.

ABB Ltd, Bosch Rexroth AG, Emerson Electric Co, Fortinet Inc, General Electric Co, Honeywell International Inc, International Business Machines Corp, Rockwell Automation Inc, Siemens AG, and Sophos Ltd are some of the leading companies operating in the North America smart life sciences manufacturing market.

Reasons to Buy:

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the North America Smart Life Sciences Manufacturing Market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in North America Smart Life Sciences Manufacturing Market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth North America Market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

1. Introduction

1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
- 1.3.1 North America Smart Life Sciences Manufacturing Market - By Component
- 1.3.2 North America Smart Life Sciences Manufacturing Market - By Technology
- 1.3.3 North America Smart Life Sciences Manufacturing Market - By End Use Industry
- 1.3.4 North America Smart Life Sciences Manufacturing Market - By Country

2. North America Smart Life Sciences Manufacturing Market - Key Takeaways

3. Research Methodology

3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. North America Smart Life Sciences Manufacturing Market - Market Landscape

4.1 Overview
4.2 North America PEST Analysis
4.3 Ecosystem Analysis
4.4 Expert Opinion

5. North America Smart Life Sciences Manufacturing Market - Key Market Dynamics

5.1 Market Drivers
- 5.1.1 Rising Adoption of Pharma 4.0
- 5.1.2 Increasing Use of Technologies in Biotechnology Laboratories
5.2 Market Restraints
- 5.2.1 Presence of Skill Gap and Need for High Initial Investment
5.3 Market Opportunities
- 5.3.1 Use of Artificial Intelligence in Cancer Research
- 5.3.2 Adoption of Virtual Reality in Smart Factory
5.4 Future Trends
- 5.4.1 Connection to Data Silos
- 5.4.2 Usage of Blockchain
- 5.4.3 Edge Computing
- 5.4.4 Predictive Maintenance
- 5.4.5 Vision-Based Quality Management
- 5.4.6 Smart Factory Trends
- 5.4.7 Emergence of Industry 5.0
5.5 Impact Analysis of Drivers and Restraints

6. North America Smart Life Sciences Manufacturing Market - North America Analysis

6.1 Overview
6.2 North America Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)

7. North America Smart Life Sciences Manufacturing Market Analysis - By Component

7.1 Overview
7.2 North America Smart Life Sciences Manufacturing Market, By Component (2022 and 2033)
7.3 Solutions
- 7.3.1 Overview
- 7.3.2 Solutions: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
7.4 Services
- 7.4.1 Overview
- 7.4.2 Services: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)

8. North America Smart Life Sciences Manufacturing Market Analysis - By Technology

8.1 Overview
8.2 North America Smart Life Sciences Manufacturing Market, By Technology (2022 and 2033)
8.3 AR/VR System
- 8.3.1 Overview
- 8.3.2 AR/VR System: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
8.4 Internet of Things (IOT)
- 8.4.1 Overview
- 8.4.2 Internet of Things (IOT): North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
8.5 Artificial Intelligence
- 8.5.1 Overview
- 8.5.2 Artificial Intelligence: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
8.6 Cyber Security
- 8.6.1 Overview
- 8.6.2 Cyber Security: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
8.7 Big Data
- 8.7.1 Overview
- 8.7.2 Big Data: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
8.8 Others
- 8.8.1 Overview
- 8.8.2 Others: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)

9. North America Smart Life Sciences Manufacturing Market Analysis - By End Use Industry

9.1 Overview
9.2 North America Smart Life Sciences Manufacturing Market, by End Use Industry (2022 and 2033)
9.3 Pharma
- 9.3.1 Overview
- 9.3.2 Pharma: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
9.4 Bio-Pharma
- 9.4.1 Overview
- 9.4.2 Bio-Pharma: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
9.5 Medical Device
- 9.5.1 Overview
- 9.5.2 Medical Device: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)

10. North America Smart Life Sciences Manufacturing Market Analysis - By Country

10.1 North America: North America Smart Life Sciences Manufacturing Market Overview

11. Industry Landscape

11.1 Overview
11.2 Market Initiatives, Expansions, and Strategic Developments
11.3 New Product/Feature Development
11.4 Mergers and Acquisitions
11.5 Agreements, Collaborations, and Joint Ventures

12. Company Profile

12.1 ABB Ltd
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Bosch Rexroth AG
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Emerson Electric Co
- 12.3.1 Business Description
- 12.3.2 Products and Services
- 12.3.3 Financial Overview
- 12.3.4 SWOT Analysis
- 12.3.5 Key Developments
12.4 Fortinet Inc
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 General Electric Co
- 12.5.1 Business Description
- 12.5.2 Products and Services
- 12.5.3 Financial Overview
- 12.5.4 SWOT Analysis
- 12.5.5 Key Developments
12.6 Honeywell International Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 International Business Machines Corp
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 Rockwell Automation Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Siemens AG
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 Sophos Ltd.
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners
13.2 Word Index

简介目录图表

List Of Tables

Table 1. North America Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
Table 2. US North America Smart Life Sciences Manufacturing Market, by Component - Revenue and Forecast to 2033 (US$ Million)
Table 3. US North America Smart Life Sciences Manufacturing Market, by Technology - Revenue and Forecast to 2033 (US$ Million)
Table 4. US North America Smart Life Sciences Manufacturing Market, Cybersecurity by Type - Revenue and Forecast to 2033 (US$ Million)
Table 5. US North America Smart Life Sciences Manufacturing Market, by End Use Industry - Revenue and Forecast to 2033 (US$ Million)
Table 6. Canada North America Smart Life Sciences Manufacturing Market, by Component - Revenue and Forecast to 2033 (US$ Million)
Table 7. Canada North America Smart Life Sciences Manufacturing Market, by Technology - Revenue and Forecast to 2033 (US$ Million)
Table 8. Canada North America Smart Life Sciences Manufacturing Market, Cybersecurity by Type - Revenue and Forecast to 2033 (US$ Million)
Table 9. Canada North America Smart Life Sciences Manufacturing Market, by End Use Industry - Revenue and Forecast to 2033 (US$ Million)
Table 10. Mexico North America Smart Life Sciences Manufacturing Market, by Component - Revenue and Forecast to 2033 (US$ Million)
Table 11. Mexico North America Smart Life Sciences Manufacturing Market, by Technology - Revenue and Forecast to 2033 (US$ Million)
Table 12. Mexico North America Smart Life Sciences Manufacturing Market, Cybersecurity by Type - Revenue and Forecast to 2033 (US$ Million)
Table 13. Mexico North America Smart Life Sciences Manufacturing Market, by End Use Industry - Revenue and Forecast to 2033 (US$ Million)
Table 14. List of Abbreviation

List Of Figures

Figure 1. North America Smart Life Sciences Manufacturing Market Segmentation
Figure 2. North America Smart Life Sciences Manufacturing Market Segmentation, By Country
Figure 3. North America Smart Life Sciences Manufacturing Market Overview
Figure 4. Solutions Held Largest Share of Component Segment in North America Smart Life Sciences Manufacturing Market
Figure 5. North America Region Is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. North America: PEST Analysis
Figure 7. Expert Opinion
Figure 1. North America Smart Life Sciences Manufacturing Market: Impact Analysis of Drivers and Restraints
Figure 2. North America Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
Figure 3. North America Smart Life Sciences Manufacturing Market Revenue Share, By Component (2022 and 2033)
Figure 4. Solutions: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 5. Services: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 6. North America Smart Life Sciences Manufacturing Market Revenue Share, By Technology (2022 and 2033)
Figure 7. AR/VR System: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 8. Internet of Things (IOT): North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 9. Artificial Intelligence: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 10. Cyber Security: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 11. Big Data: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 12. Others: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 13. North America Smart Life Sciences Manufacturing Market Revenue Share, By End Use Industry (2022 and 2033)
Figure 14. Pharma: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 15. Bio-Pharma : North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 16. Medical Device: North America Smart Life Sciences Manufacturing Market - Revenue, and Forecast to 2033 (US$ Million)
Figure 17. North America Smart Life Sciences Manufacturing Market, by Key Country - Revenue (2022) (US$ Million)
Figure 18. North America Smart Life Sciences Manufacturing Market Revenue Share, by Key Country, (2022 & 2033)
Figure 19. US: North America Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
Figure 20. Canada: North America Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)
Figure 21. Mexico: North America Smart Life Sciences Manufacturing Market - Revenue and Forecast to 2033 (US$ Million)